Young onset Dystonia-Parkinsonism, Intellectual Disability & Mineral deposits in Basal ganglia – Think “RAB39B” mutation
Objective: Please consider RAB39B gene when encountering a young onset dystonia Parkinson phenotype alongside non-progressive intellectual disability and brain mineral deposits. This consideration is crucial…Effectiveness of Lead-Point in Parkinson`s Model of STN-MER with DBS: A Study of Predicting Motor progression
Objective: To inquiry into the correlation between progression and active point of contact site expects an adjustment for functional (anatomical-structural) variation. Background: Within the Parkinson…Movement disorders in Brain Sagging Syndrome- A Systematic Review
Objective: Objective: This study aims to systematically review the array of movement disorders observed in patients diagnosed with brain sagging syndrome (BSS) secondary to spontaneous…Effect of rehabilitation therapy on the motor functions in patients with multiple system atrophy
Objective: We aim to evaluated the effect of rehabilitation therapy on the motor symptoms and activities of daily living in patients with MSA using an…Cardiovascular Associations of Cortical Lewy Bodies in the Oldest Old: The 90+ study
Objective: To identify potential risk factors for cortical Lewy Bodies (CLB) in the oldest-old (> 90 years old), we investigated if cardiovascular medical histories, medication…New onset movement disorders following COVID-19 infection
Objective: To determine the prevalence and phenotype of movement disorders following SARS-CoV-2 infection in hospitalised individuals. Background: Although movement disorders, including parkinsonism, following SARS-CoV-2 (COVID-19)…Characterization of Autoimmune Parkinsonism. A case series
Objective: To report the presentation features in autoimmune parkinsonism in a neurological reference center in Arequipa Peru. Background: Epidemiological studies suggest that a rare association…Clinical and neurological features of the course of Parkinsonism disease in patients with CKD with cystatin C disorder
Objective: To study the effect of cystatin C on the development of cognitive disorders(CD) in patients with CKD(Chronic kidney disease) and vascular parkinsonism Background: Clinical…No Association between Anemia and Risk of Parkinson’s Disease: Evidence From A Meta-Analysis Using Real-World Evidence
Objective: To explore the association between anemia and the risk of Parkinson’s disease. Background: Parkinson’s disease (PD) is a common progressive neurodegenerative neurological disorder. More than…Real-World Multicenter Analysis of Levodopa Equivalent Daily Dosage Algorithms- Capturing Geographical and Demographic Disparities in Parkinson’s Disease Therapy Spanning Six Countries and Two Continents
Objective: To assess the influence of updated Levodopa Equivalent Daily Dosage (LEDD) conversion factors in capturing the newer therapies in Parkinson’s Disease (PD) and therapy…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 388
- Next Page »